S&P revises Arkema outlook to stable on weaker demand

S&P Global Ratings revised its outlook on Arkema (EPA:AKE) to stable from positive, while affirming its 'BBB+/A-2' ratings, citing weakened end-market demand in Europe and North America, particularly in construction and automotive, which is not expected to recover significantly before mid-2026. This led to a 0.7% organic sales decline in Q1 2025 and expectations for flat adjusted EBITDA in 2025. Despite the demand challenges, S&P acknowledged Arkema's improved business strengths, including enhanced scale, geographic footprint, and a strategic shift to specialty materials, now 92% of sales, which is expected to bolster earnings resilience. The rating remains sensitive to further demand deterioration or significant debt-funded acquisitions, while an upgrade would require sustained stronger financial metrics.

Analysis

S&P Global Ratings has revised its outlook on Arkema (EPA:AKE) to 'stable' from 'positive', while affirming the 'BBB+/A-2' rating, signaling a delay in the company's expected credit profile improvement. The revision is directly attributed to persistent weakness in key end-markets such as construction and automotive, particularly in Europe and North America, with a significant recovery not anticipated before mid-2026. This macroeconomic pressure is reflected in Arkema's Q1 2025 results, where organic sales declined by 0.7%, and S&P forecasts that adjusted EBITDA will remain flat year-over-year in 2025 at approximately €1.5 billion. Despite these cyclical headwinds, S&P acknowledges Arkema's favorable strategic progress. The company has successfully shifted its portfolio to where specialty materials now account for 92% of total sales, a move expected to enhance the resilience of earnings and cash flows. Furthermore, Arkema has improved its operational scale and geographic diversification, with its Asia-Pacific business showing resilience. The current rating is supported by projected funds from operations (FFO) to debt between 40%-45%, but a potential downgrade is contingent on this metric falling below 35% or the execution of a large debt-funded acquisition.

Key Decisions for Investors

• Investors should moderate near-term performance expectations for Arkema, as the revised 'stable' outlook and flat EBITDA forecast for 2025 indicate a period of consolidation rather than growth, driven by prolonged demand weakness.
• Monitor macroeconomic indicators in Europe and North America closely, as further deterioration in demand or a large debt-financed acquisition are the key triggers S&P identified for a potential credit rating downgrade.
• For long-term investors, the company's strategic pivot to 92% specialty materials and strength in Asia could offer defensive qualities, warranting a hold decision through the current cyclical trough for those with a higher risk tolerance.